IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Prosight Management, LP

Portfolio Profile

CIK: 0001617201 | DALLAS, TX

Investment Profile

Style

Yield

Turnover

High

Orientation

Concentrated trader
$580.4M
AUM
36
Positions
70.73%
Top 10 Conc.
96.79%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Lakefront Biotherapeutics NV(GLPG)2,043,344$61.3M10.56%
2Janux Therapeutics Inc(JANX)3,804,481$58.4M10.07%
3Nektar Therapeutics(NKTR)810,000$56.5M9.74%
4Boston Scientific Corp(BSX)1,270,273$54.2M9.34%
5Shattuck Labs Inc(STTK)5,957,877$41.3M7.12%

Sector Allocation

Latest filing, equity positions only

Healthcare99.58% · $577.9M
Unclassified0.21% · $1.2M
Technology0.21% · $1.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Unclassified4.64%0.21%-4.43%
Healthcare95.2%99.58%+4.38%

AUM History

$315.5M | 41 pos.
$249.1M | 35 pos.
$359.5M | 44 pos.
$334.6M | 46 pos.
$406.4M | 47 pos.
$361.8M | 36 pos.
6
Insmed Inc(INSM)
375,609
$40.0M
6.90%
7Alnylam Pharmaceuticals Inc(ALNY)98,080$29.5M5.09%
8Syndax Pharmaceuticals Inc(SNDX)1,200,000$26.2M4.52%
9Kura Oncology Inc(KURA)2,021,964$22.2M3.82%
10Alkermes PLC(ALKS)394,389$20.7M3.56%
Technology0%0.21%+0.21%
Industrials0.16%0%-0.16%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Mid Cap37.08%39.93%+2.85%
Small Cap34.1%29.26%-4.84%
Large Cap15.1%26.3%+11.2%
Micro Cap9.07%4.3%-4.77%
Unclassified4.64%0.21%-4.43%
$304.3M | 38 pos.
$410.1M | 39 pos.
$428.8M | 44 pos.
$483.9M | 38 pos.
$609.8M | 46 pos.
$580.4M | 36 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

5
New
15
Closed
16
Increased
15
Decreased
0
Unchanged